share_log

Craig-Hallum Initiates Coverage On MaxCyte With Buy Rating, Announces Price Target of $7

Craig-Hallum Initiates Coverage On MaxCyte With Buy Rating, Announces Price Target of $7

Craig-Hallum 以買入評級啓動對 MaxCyte 的報道,宣佈目標股價爲 7 美元
Benzinga ·  2023/11/29 11:10

Craig-Hallum analyst Matt Hewitt initiates coverage on MaxCyte (NASDAQ:MXCT) with a Buy rating and announces Price Target of $7.

Craig-Hallum分析師馬特·休伊特以買入評級開始對MaxCyte(納斯達克股票代碼:MXCT)進行報道,並宣佈目標股價爲7美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論